Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan

OBJECTIVE: We examined the correlation between the dosing regimen of oral prednisolone (PSL) and the achievement of minimal manifestation status or better on PSL ≤5 mg/day lasting >6 months (the treatment target) in patients with generalised myasthenia gravis (MG). METHODS: We classified 590 pati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Neurol Neurosurg Psychiatry
Autores principales: Imai, Tomihiro, Utsugisawa, Kimiaki, Murai, Hiroyuki, Tsuda, Emiko, Nagane, Yuriko, Suzuki, Yasushi, Minami, Naoya, Uzawa, Akiyuki, Kawaguchi, Naoki, Masuda, Masayuki, Konno, Shingo, Suzuki, Hidekazu, Akaishi, Tetsuya, Aoki, Masashi
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2018
Materias:
Neuromuscular
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5909754/
https://ncbi.nlm.nih.gov/pubmed/29175893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2017-316625
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares